Drugs / Trichuris suis ova (TSO)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01953354 | Nov 2013 → Nov 2015 | ulcerative colitis | National Institute of Allergy and Infectious Diseases (NIAID) | Terminated | Missed primary Stop: Business |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trichuris suis ova (TSO) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01953354 ↗ |
| Known as | 7500 Trichuris suis ova (7500 TSO ) | “7500 Trichuris suis ova (7500 TSO )” NCT01953354 ↗ |
| Route | Oral | “Six doses of TSO orally over a ten-week period” NCT01953354 ↗ |